San Francisco, CA, United States of America

Trevor Hryce

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Roche Molecular Systems, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Trevor Hryce

Introduction

Trevor Hryce is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid capture technologies. His work has implications for various applications in medical diagnostics and research.

Latest Patents

Trevor holds 1 patent for his invention titled "Successive capture of nucleic acid by magnetic glass particles." This patent outlines methods and components for the effective capture of nucleic acids using magnetic glass particles, showcasing his innovative approach to enhancing molecular capture techniques.

Career Highlights

Throughout his career, Trevor has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and F. Hoffmann-La Roche AG, where he contributed to advancing molecular diagnostic technologies. His experience in these organizations has helped him refine his skills and knowledge in the field.

Collaborations

Trevor has collaborated with talented individuals such as Jennifer Griswold and Karan Kampani. These partnerships have fostered a creative environment that has led to innovative solutions in their respective projects.

Conclusion

Trevor Hryce's contributions to the field of molecular biology through his patent and career experiences highlight his role as an influential inventor. His work continues to inspire advancements in nucleic acid capture technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…